Related Experiment Video

Updated: May 19, 2026

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

New strategies in sarcoma therapy: linking biology and novel agents

Katherine A Janeway1, Robert G Maki

  • 1Deparment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|August 30, 2012
PubMed

Insights

Personalized cancer therapy uses genetic insights to guide treatment. Sarcoma research faces challenges linking specific cancer types to new drugs, requiring focused clinical trials.

Area of Science:

  • Oncology
  • Genetics
  • Therapeutics

Background:

  • Cancer treatment is shifting towards personalized medicine based on genetic alterations.
  • Sarcomas, diverse cancers of soft tissue and bone, exemplify this paradigm.
  • Numerous obstacles hinder the connection of specific sarcoma types with novel therapeutic agents.

Purpose of the Study:

  • To outline therapeutic opportunities and challenges in clinical sarcoma research.
  • To highlight specific sarcoma examples nearing breakthroughs and those with unmet expectations.
  • To discuss strategies for improving clinical trial design in sarcoma research.

Main Methods:

  • Perspective review of current sarcoma research landscape.
  • Analysis of therapeutic opportunities and hurdles.
  • Case examples of sarcoma breakthroughs and disappointments.
  • Discussion on clinical trial design, including biomarker and histology-specific arms.

Main Results:

  • Sarcoma research presents significant opportunities but also faces substantial barriers.
  • Some sarcoma types are on the cusp of new therapeutic breakthroughs.
  • Other sarcoma investigations have not met initial expectations.
  • Focused clinical trial designs are crucial for efficient and inclusive research.

Conclusions:

  • Personalized medicine holds promise for sarcoma treatment, but challenges remain.
  • Overcoming barriers requires strategic approaches, including optimized clinical trial design.
  • Biomarker and histology-specific trials can advance sarcoma therapeutics effectively.

More Related Videos

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

The In ovo CAM-assay as a Xenograft Model for Sarcoma12:44

The In ovo CAM-assay as a Xenograft Model for Sarcoma

Published on: July 17, 2013

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...